Clinical trial
Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With…
NCT00119301 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00119301 |
|---|---|
| Title | Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent Osteosarcoma |
| Official title | Phase I Study of High Dose Methotrexate With Simultaneous Trimetrexate and Leucovorin in Patients With Recurrent Osteosarcoma |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | leucovorin calcium, methotrexate, trimetrexate glucuronate |
| Enrollment | 18 |
| Start date | Apr 1, 2005 |
| Primary completion | Apr 1, 2007 |
| First posted | Jul 13, 2005 |
| Last update posted | Jan 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: